Log in
  • PO Box 450 Mawson ACT, 2607 Australia

  • 02 6260 4022

Backing Complementary Medicines Manufacturing: Naturally Good for Australia

08 Oct 2020 2:36 PM | Anonymous member (Administrator)

In a Briefing with Industry Minister Karen Andrews, details of the Government’s manufacturing package were detailed and welcomed by CMA chief executive Carl Gibson yesterday.

Carl Gibson: "Our industry not only continues to provide jobs for Australians, but this trend is set to continue."

“As a representative of Australia’s world-class complementary medicines industry, I welcome the Government’s manufacturing pack. I am proud to say backed by science, technology and regulation standards bar none, our industry not only continues to provide jobs for Australians, but this trend is set to continue,” said Carl Gibson.

The move is part of the Economic Recovery Plan to lead Australia out of the COVID-19 crisis as part of the Government’s Plan to rebuild the economy, create jobs and recover from the COVID-19 recession.

Around $1.5 billion in new funding over the next four years is part of the Modern Manufacturing Strategy designed to make Australian manufacturers more competitive, more resilient, and better able to scale-up to take on the world.

Australian Complementary medicines are manufactured to the highest standards in the world. Manufacturers must hold a licence from the Regulator, The Therapeutic Goods Administration and adhere to Good Manufacturing Practice and the Pharmaceutical Inspection Co-operation Scheme.

“Incorporating science and modern technology, our agile manufacturers have risen to the challenge with regularly audited manufacturing facilities ensuring state-of-the-art manufacturing technologies to take more of our quality products to the world,” adds Carl Gibson.

Minister for Industry, Science and Technology, Karen Andrews, said the investments highlight the Government’s commitment to making science and technology work for industry, which is a key pillar of the Modern Manufacturing Strategy. “A resilient and competitive manufacturing sector should be at the heart of a modern Australian economy, and this Strategy will create jobs, drive our economy forward and make Australia more secure.”

The 2020-21 Budget includes an investment of $1.5 billion over four years for the Modern Manufacturing Strategy to allow Australian manufacturers to scale up, compete internationally and create more jobs.

Copyright © 2019 Complementary Medicines Australia. All rights reserved.

Powered by Wild Apricot Membership Software